Device Trial Radar · NCT00605826
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
Last checked: Nov 20, 2026Latest source record: Aug 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
206
Actual
Start
Sep 7, 2006
Primary completion
Nov 23, 2009
Study completion Nov 23, 2009
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Oceana Therapeutics, Inc.; Galderma R&D
- First posted
- Jan 31, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effectiveness and safety of NASHA/Dx when used as an injectable bulking agent in the treatment of fecal incontinence. The study includes a 6-month blinded sham-controlled phase, followed by an open-label phase.
Conditions
- Fecal Incontinence
Interventions
NASHA/Dx (Solesta) GelDevice
Injection of 4 x 1ml of NASHA/Dx Gel at the start of the blinded phase.
Sham InjectionDevice
Sham injection at the start of the blinded phase.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Are Responder50.Time frame: 6 months after last blinded treatment
- Percentage of Participants Who Are Responder25.Time frame: 12 months after last treatment
Locations
13 sites in 4 countries. Site status is shown where the registry gives one.
University of California, San Francisco, Center for Pelvic Physiology, Dept. of Surgery
San Francisco, California
University of South Florida College of Medicine, Tampa General Hospital
Tampa, Florida
Lahey Clinic, Department of Colon & Rectal Surgery
Burlington, Massachusetts
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.